​

Alto Neuroscience Ownership | Who Owns Alto Neuroscience?

OverviewFinancialsChart

Alto Neuroscience Ownership Summary

Alto Neuroscience is owned by 77.07% institutional investors, 7.48% insiders, and 15.45% retail investors. Nelson, van denburg & campbell wealth management group is the largest institutional shareholder, holding 0% of ANRO shares.

ANRO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAlto Neuroscience77.07%7.48%15.45%
SectorHealthcare Stocks 279.19%10.58%-189.76%
IndustryBiotech Stocks 63.97%10.68%25.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nelson, van denburg & campbell wealth management group---
Corton capital---
Advisor group---
Skandinaviska enskilda banken ab (publ)---
Jane street group---
Lmr partners llp---
Wellington management group llp---
Atom investors lp---
Russell investments group---
Td asset management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nelson, van denburg & campbell wealth management group---
Corton capital---
Advisor group---
Skandinaviska enskilda banken ab (publ)---
Jane street group---
Lmr partners llp---
Wellington management group llp---
Atom investors lp---
Russell investments group---
Td asset management---

Top Buyers

HolderShares% AssetsChange
Russell investments group---177.00
Nelson, van denburg & campbell wealth management group---249.00
Advisor group---883.00
Atom investors lp---10.42K
Skandinaviska enskilda banken ab (publ)---17.72K

Top Sellers

HolderShares% AssetsChange
Td asset management---110.79K
Wellington management group llp---77.15K
Lmr partners llp---51.70K
Corton capital---33.55K
Jane street group---18.60K

Sold Out

HolderChange
Russell investments group-177.00
Nelson, van denburg & campbell wealth management group-249.00
Advisor group-883.00
Atom investors lp-10.42K
Skandinaviska enskilda banken ab (publ)-17.72K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025867.50%20,845,493-6.06%771.14%39-23.53%26100.00%
Dec 31, 202481-5.81%22,530,140-1.78%831.15%52-21.21%1344.44%
Sep 30, 20248648.28%22,939,57423.33%851.79%6669.23%9-10.00%
Jun 30, 20245811.54%18,600,67416.67%691.96%39-25.00%10-
Mar 31, 202452-15,943,412-59-52---

Recent Insider Transactions

DateNameRoleActivityValue
Jul 10, 2024Savitz Adam CHIEF MEDICAL OFFICERBuy$38.75K
Jul 09, 2024Savitz Adam CHIEF MEDICAL OFFICERBuy$18.25K
Jul 09, 2024Savitz Adam CHIEF MEDICAL OFFICERBuy$133.83K

Insider Transactions Trends

DateBuySell
2025 Q2--
2025 Q1--
2024 Q33-

ANRO Ownership FAQ

Who Owns Alto Neuroscience?

Alto Neuroscience shareholders are primarily institutional investors at 77.07%, followed by 7.48% insiders and 15.45% retail investors. The average institutional ownership in Alto Neuroscience's industry, Biotech Stocks , is 63.97%, which Alto Neuroscience exceeds.

Who owns the most shares of Alto Neuroscience?

Alto Neuroscience’s largest shareholders are Nelson, van denburg & campbell wealth management group (0 shares, 0%), Corton capital (0 shares, 0%), and Advisor group (0 shares, 0%). Together, they hold 0% of Alto Neuroscience’s total shares outstanding.

Does Blackrock own Alto Neuroscience?

BlackRock is not among the top 10 institutional shareholders of Alto Neuroscience.

Who is Alto Neuroscience’s biggest shareholder by percentage of total assets invested?

Nelson, van denburg & campbell wealth management group is Alto Neuroscience’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Alto Neuroscience shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools